| Home > Documents in Process > Multi‐tracer PET monitoring of an immunomodulatory therapy in 4R tauopathy: Evaluating a novel drug's impact on glial function and protein pathology > Access to Fulltext |
| Restricted | |||||||
DZNE-2026-00041
|
|||||||
| version 1 |
| ||||||